Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer's disease assessment scale that broaden its scope

Alzheimer Disease and Associated Disorders

Volumn 11, Issue SUPPL. 2, 1997, Pages

  Mohs, Richard C ^a,j   Knopman, David ^b   Petersen, Ronald C ^c   Ferris, Steven H ^d   Ernesto, Chris ^e   Grundman, Michael ^e   Sano, Mary ^f   Bieliauskas, Linas ^g   Geldmacher, David ^h   Clark, Chris ⁱ   Thal, Leon J ^e  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MAYO CLINIC   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

Alzheimer's disease; Assessment scales; Cognitive impairment

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ATTENTION; CLINICAL TRIAL; COGNITION; DISEASE SEVERITY; DRUG SCREENING; HUMAN; LEARNING; MAZE TEST; MEMORY; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RECALL; RECOGNITION;

AGED; ALZHEIMER DISEASE; CLINICAL TRIALS; COGNITION; FEMALE; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; TASK PERFORMANCE AND ANALYSIS;

EID: 0030814418     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Christensen KJ, Mutchup KS, Norstrom S, et al. A cognitive battery for dementia. Development and measurement characteristics Psychol Assessment 1991;3:168-74.
2. Ferris SF, Mackell JM, Mohs R. A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. Alzheimer Dis Assoc Disord 1997:11(suppl 2):S1-12 (this issue).
3. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive status of patients for the clinician. J Psychiatr Res 1975;12:189-98.
4. Goodglass H, Kaplan E. The assessment of aphasia and related disorders. Philadelphia: Lea & Febiger, 1972.
5. Hill RD, Backman L, Fratiglioni F. Determinants of functional abilities in dementia. J Am Geriatr Soc 1995;43:1092-7.
6. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-72.
7. Lezak M. Neuropsychological assessment. 2nd ed. New York: Oxford University Press, 1982.
8. Locasio JJ, Growdon JH, Corkin S. Cognitive test performance in detecting, staging, and tracking Alzheimer's disease Arch Neurol 1995;52:1087-99.
9. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-4.
10. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-65.
11. Morris JC, McKeel DW, Storandt M, et al. Very mild Alzheimer's disease: informant-based clinical, psychometric and pathological distinction from normal aging. Neurology 1991;41:469-78.
12. Neisser U. Visual search. Sci Am 1964;210:94-102.
13. Pavio A, Yuille JC, Madigan SA. Concreteness, imagery, and meaningfulness values for 925 nouns. J Exp Psychol 1968;76:1-25.
14. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274-8.
15. Reisberg B, Ferris SH, deLeon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia Am J Psychiatry 1982;139:1136-9.
16. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-64.
17. Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer's disease: measurement, rate and predictors of cognitive deterioration. Am J Psychiatry 1994;151:390-6.
18. Thomdyke EL, Lorge I. The teacher's wordbook of 30,000 words. New York: Teachers College, Bureau of Publications, 1944.
19. Warrington EK, James M. Disorders of visual perception in patients with localized cerebral lesions. Neuropsychologia 1967;5:253-66.
20. Welsh K, Butters N, Hughes J, et al. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measure. Arch Neurol 1991;48:278-81.
21. Welsh KA, Butters N, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 1994;44:609-14.
22. Yesavage JA, Tinklenberg JR, Hollister LE, Berger PA. Vasodilators in senile dementia: a review of the literature. Arch Gen Psychiatry 1979;36:220-3.